ArticleOpen veterinary journal2026
Clinical and sero-diagnosis of feline leptosprosis in the sleman region of Yogyakarta, Indonesia.
Article in Open veterinary journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Leptospirosis is a zoonotic disease caused by pathogenic Aim: This study aimed to estimate the seroprevalence of leptospirosis in cats, identify circulating Leptospira serovars, and descriptively characterize clinical signs and selected renal and hepatic laboratory findings in naturally exposed cats in Sleman Regency, Indonesia. Methods: A total of 116 pubertal cats from Sleman Regency, Special Region of Yogyakarta, Indonesia, were clinically examined. Three millilitres of blood were collected for the MAT, routine hematology, and biochemical analyses, including renal biomarkers [blood urea nitrogen (BUN), creatinine, symmetric dimethylarginine, hepatic biomarkers alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin, albumin, and globulin], and the inflammatory marker feline serum amyloid A (fSAA). Leptospirosis was diagnosed at a MAT titer ≥1:100 against 14 Results: Of the 116 cats, 12 (10.34%) were seropositive for leptospirosis. Serovar Bataviae was predominant (83.34%), while Ballum and Icterohaemorrhagiae each accounted for 8.33%. Most seropositive cats (66.67%) were clinically normal at the time of sampling, whereas 25% showed nonspecific signs such as anorexia, fever, icterus, lethargy, vomiting, or diarrhea. One cat (8.33%) presented with clinical signs consistent with renal involvement.The hematological parameters were within the reference ranges in more than half of the seropositive cats (58.33%), whereas leukocytosis indicative of inflammation was observed in 25% and mild anemia in 16.67%. Renal biomarkers (BUN, creatinine) remained within the reference intervals in 91.67% of seropositive cats, indicating minimal renal involvement at the time of sampling. Hepatic alterations were more frequently observed, with elevated ALT and AST levels in 25% of cats and increased total bilirubin or altered albumin-to-globulin ratios in 41.67% of cats. Elevated fSAA concentrations were detected in 33.33% of seropositive cats, indicating subclinical inflammatory responses. Conclusion: This study demonstrates the presence of feline leptospiral exposure in Sleman Regency, with a seroprevalence of 10.34%, predominantly associated with
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.